Article in Annals of neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors.
Eric L StulbergDepartment of Neurology, University of Utah, Salt Lake City, UT, USA.ORCID 0000-0002-3075-4597
Lynda LisabethDepartment of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA.ORCID 0000-0001-5539-5933
Andrea L C SchneiderDepartment of Neurology, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0003-0026-5052
Lesli SkolarusDepartment of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Kiarri N KershawDepartment of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Alexander R ZheutlinDepartment of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Benjamin R E HarrisDepartment of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.
Daniel SarpongDepartment of General Internal Medicine, Center for Brain and Mind Health, Yale University School of Medicine, New Haven, CT, USA.
Ka-Ho WongDepartment of Neurology, University of Utah, Salt Lake City, UT, USA.
Kevin N ShethDepartment of Neurology, Center for Brain and Mind Health, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0003-2003-5473
Adam de HavenonDepartment of Neurology, Center for Brain and Mind Health, Yale University School of Medicine, New Haven, CT, USA.
Funding
STROKE SURVEILLANCE IN A BIETHNIC COMMUNITYR01NS038916 · NINDS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI LISABETH, LYNDA D, MORGENSTERN, LEWIS B · 1999 to 2023
$20.9M
Anticoagulation in ICH Survivors for Prevention and Recovery (ASPIRE)U01NS106513 · NINDS · YALE UNIVERSITY · PI Hooman Kamel, Kevin Navin Sheth · 2019 to 2026
$20.6M
Social networks and risk of delayed arrival to the hospital during strokeR01MD016178 · NIMHD · BRIGHAM AND WOMEN'S HOSPITAL · PI Amar Dhand, Kevin Navin Sheth · 2022 to 2026
$3.7M
The Recovery in Stroke Using PAP (RISE UP) StudyR01NR018335 · NINR · YALE UNIVERSITY · PI REDEKER, NANCY S, SHETH, KEVIN NAVIN · 2019 to 2023
$3.4M
Improving Post-Acute Care to Reduce Ethnic Stroke DisparitiesR01NS107463 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LISABETH, LYNDA D, MORGENSTERN, LEWIS B · 2019 to 2023
$3.3M
Southern New England Partnership In Stroke Research, Innovation and Treatment (SPIRIT)U24NS107215 · NINDS · YALE UNIVERSITY · PI MARK Jay ALBERTS, Karen L Furie · 2018 to 2026
$3.0M
CAPTIVA-MRIUH3NS130228 · NINDS · YALE UNIVERSITY · PI Sepideh Amin-Hanjani, Arindam Rano Chatterjee · 2025 to 2026
$2.8M
Blood Pressure Variability and Ischemic Stroke Outcome (BP-VISO)R01NS130189 · NINDS · YALE UNIVERSITY · PI Adam H. de Havenon · 2023 to 2026
$2.0M
CAPTIVA-MRIUG3NS130228 · NINDS · YALE UNIVERSITY · PI AMIN-HANJANI, SEPIDEH, CHATTERJEE, ARINDAM R. · 2023 to 2023
$1.9M
Improved glyburide therapy via acid- triggered release functional nanoparticles and therapeutic imagingR01NS110721 · NINDS · YALE UNIVERSITY · PI SHETH, KEVIN NAVIN, ZHOU, JIANGBING · 2019 to 2023
$1.9M
Yale-METRO Metropolitan Emergency Trial netwoRK to advance patient OutcomesU24NS129500 · NINDS · YALE UNIVERSITY · PI Gail D'Onofrio, Kevin Navin Sheth · 2023 to 2026
$1.7M
Yale Clinical Site: Investigations For Improved Neurological Treatments at Yale (INFINITY)U24NS107136 · NINDS · YALE UNIVERSITY · PI SHETH, KEVIN NAVIN, SPUDICH, SERENA S · 2018 to 2022
Socioeconomic status (SES) is a multi-faceted theoretical construct associated with stroke risk and outcomes. Knowing which SES measures best correlate with population stroke metrics would improve its accounting in observational research and inform interventions. Using the Centers for Disease Control and Prevention's (CDC) Population Level Analysis and Community Estimates (PLACES) and other publicly available databases, we conducted an ecological study comparing correlations of different United States county-level SES, health care access and clinical risk factor measures with age-adjusted stroke prevalence. The prevalence of adults living below 150% of the federal poverty level most strongly correlated with stroke prevalence compared to other SES and non-SES measures (correlation coefficient = 0.908, R
Indexed as
StrokeAdultAgedFemaleHealth Services AccessibilityHumansMaleMiddle AgedPrevalenceRisk FactorsSocial ClassSocioeconomic FactorsUnited States
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Correlations of Socioeconomic and Clinical Determinants with United States County-Level Stroke Prevalence. · full record | OpenQuestion